Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
American Heart Journal|November 26, 2013
Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): an international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary interventionPhilippe Gabriel Steg, Arnoud van 't Hof, Peter Clemmensen, et al.The New England Journal of Medicine|November 1, 2013
Bivalirudin started during emergency transport for primary PCIPhilippe Gabriel Steg, Arnoud van 't Hof, Christian W Hamm, et al.Journal of the American College of Cardiology|October 1, 2013
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleedingUdaya S Tantry, Laurent Bonello, Daniel Aradi, et al.JACC. Cardiovascular Interventions|June 17, 2019
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary InterventionDirk Sibbing, Daniel Aradi, Dimitrios Alexopoulos, et al.JACC. Cardiovascular Interventions|November 27, 2024
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 UpdateDominick J Angiolillo, Mattia Galli, Dimitrios Alexopoulos, et al.Circulation|June 19, 2023
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research ConsortiumDavide Capodanno, Roxana Mehran, Mitchell W Krucoff, et al.Cardiovascular Diabetology|December 19, 2020
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 RegistryGiuseppe De Luca, Miha Cercek, Lisette Okkels Jensen, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 19, 2021
Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registryGiuseppe De Luca, Miha Cercek, Lisette Okkels Jensen, et al.Atherosclerosis|August 14, 2021
Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registryGiuseppe De Luca, Niels Debel, Miha Cercek, et al.Journal of the American College of Cardiology|November 13, 2020
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMIGiuseppe De Luca, Monica Verdoia, Miha Cercek, et al.Pageof 6